A carregar...
Imaging outcome measures for progressive multiple sclerosis trials
Imaging markers that are reliable, reproducible and sensitive to neurodegenerative changes in progressive multiple sclerosis (MS) can enhance the development of new medications with a neuroprotective mode-of-action. Accordingly, in recent years, a considerable number of imaging biomarkers have been...
Na minha lista:
| Publicado no: | Mult Scler |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5650056/ https://ncbi.nlm.nih.gov/pubmed/29041865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517729456 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|